OF ten COVID-19 candidate vaccines in their final human trials, two reported highly promising initial results of their final Phase 3 human trials early this month. American drugmaker Pfizer, in partnership with Germany’s BioNTech, announced on November 9 that tests showed that its vaccine was more than 90 percent effective in tests involving 43,000 […]